A bioinformatics approach to cuprizone model of multiple sclerosis: Focus on glial cells

Glial cell pathways in MS model

Authors

DOI:

https://doi.org/10.5281/zenodo.14557832

Keywords:

Glial cells, Cuprizone, Demyelination, Multiple sclerosis, Bioinformatics databases

Abstract

Multiple sclerosis is a multifaceted demyelinating autoimmune disease primarily affecting myeline sheath in the central nervous system. There is currently no definitive treatment for this disease. Neuroinflammation is thought to be the main cause underlying the disease. Cuprizone is a copper-chelating chemical compound, and commonly used in experimental model of multiple sclerosis. Therefore, in this study it was aimed to investigate the changes in molecular pathways in glial cells induced by cuprizone demyelination model by using different methods.

Cuprizone-gene interaction analysis was done with The Comparative Toxicogenomics Database. The Gene Expression Omnibus database was used to access bioinformatics datasets. The gene expression data were analyzed to compare cuprizone fed and normal diet animal brain samples. Differentially expressed genes were determined by using bioinformatics tools. Pathway analysis was studied with Enrichr. The String Database was used to show protein-protein interactions network.

In this study, it has shown that the cuprizone model of multiple sclerosis mainly targets oligodendrocytes. However, microglia and astrocyte related signaling pathways are also affected by multiple sclerosis. Thus, combined therapeutic approaches are needed to multiple sclerosis treatment.

Downloads

Download data is not yet available.

References

Jessen KR. Glial cells. The International Journal of Biochemistry & Cell Biology. 2004;36:1861–67. https://doi.org/10.1016/j.biocel.2004.02.023

Chiareli RA, Carvalho GA, Marques BL, et al. The role of astrocytes in the neurorepair process. Frontiers in Cell and Developmental Biology. 2021;9:665795. https://doi.org/10.3389/fcell.2021.665795

Skripuletz T, Hackstette D, Bauer K, et al. Astrocytes regulate myelin clearance through recruitment of microglia during cuprizone-induced demyelination. Brain. 2013;136:147–67. https://doi.org/10.1093/brain/aws262

Xiao Y and Czopka T. Myelination-independent functions of oligodendrocyte precursor cells in health and disease. Nature Neuroscience. 2023;26:1663–9. https://doi.org/10.1038/s41593-023-01423-3

Colonna M and Butovsky O. Microglia function in the central nervous system during health and neurodegeneration. Annual Review of Immunology. 2017;35:441–68. https://doi.org/10.1146/annurev-immunol-051116-052358

Sen MK, Mahns DA, Coorssen JR, et al. The roles of microglia and astrocytes in phagocytosis and myelination: insights from the cuprizone model of multiple sclerosis. Glia. 2022;70:1215–50. https://doi.org/10.1002/glia.24148

Kipp M, Clarner T, Dang J, et al. The cuprizone animal model: new insights into an old story. Acta Neuropathologica. 2009;118:723–36. https://doi.org/10.1007/s00401-009-0591-3

Goldberg J, Clarner T, Beyer C, et al. Anatomical distribution of cuprizone-induced lesions in C57BL6 mice. Journal of Molecular Neuroscience. 2015;57:166–75. https://doi.org/10.1007/s12031-015-0595-5

Kipp M. Astrocytes: lessons learned from the cuprizone model. International Journal of Molecular Sciences. 2023;24. https://doi.org/10.3390/ijms242216420

Escribano BM, Muñoz-Jurado A, Luque E, et al. Effect of the combination of different therapies on oxidative stress in the experimental model of multiple sclerosis. Neuroscience. 2023;529:116–28. https://doi.org/10.1016/j.neuroscience.2023.08.005

Ma Y, Wang F, Zhao Q, et al. Identifying diagnostic markers and constructing predictive models for oxidative stress in multiple sclerosis. International Journal of Molecular Sciences. 2024;25. https://doi.org/10.3390/ijms25147551

Tobore TO. Oxidative/nitroxidative stress and multiple sclerosis. Journal of Molecular Neuroscience. 2021;71:506–14. https://doi.org/10.1007/s12031-020-01672-y

Sághy É, Sipos É, Ács P, et al. TRPA1 deficiency is protective in cuprizone-induced demyelination-a new target against oligodendrocyte apoptosis. Glia. 2016;64:2166–80. https://doi.org/10.1002/glia.23051

Kriszta G, Nemes B, Sándor Z, et al. Investigation of cuprizone-ınduced demyelination in mGFAP-driven conditional transient receptor potential ankyrin 1 (TRPA1) receptor knockout mice. Cells. 2019;9. https://doi.org/10.3390/cells9010081

Kipp M. How to use the cuprizone model to study de- and remyelination. International Journal of Molecular Sciences. 2024;25. https://doi.org/10.3390/ijms25031445

Davis AP, Wiegers TC, Sciaky D, et al. Comparative toxicogenomics database’s 20th anniversary: update 2025. Nucleic Acids Research. 2024. https://doi.org/10.1093/nar/gkae883

Takahashi K, Kanekiyo K, Sakuda K, et al. Brain-specific glycosylation of protein tyrosine phosphatase receptor type Z (PTPRZ) marks a demyelination-associated astrocyte subtype. Journal of Neurochemistry. 2023;166:547–59. https://doi.org/10.1111/jnc.15820

Moyon S, Dubessy AL, Aigrot MS, et al. Demyelination causes adult CNS progenitors to revert to an immature state and express immune cues that support their migration. The Journal of Neuroscience. 2015;35:4–20. https://doi.org/10.1523/JNEUROSCI.0849-14.2015

Işcan E. Determination the effect of YAP/TAZ signaling pathway on mechanical stress induced hypertrophic scar formation by GEO2R. Turkiye Klinikleri Journal of Dermatolgy. 2021;31:109–17. https://doi.org/10.5336/dermato.2020-80691

Rahmat-Zaie R, Amini J, Haddadi M, et al. TNF-α/STAT1/CXCL10 mutual inflammatory axis that contributes to the pathogenesis of experimental models of multiple sclerosis: A promising signaling pathway for targeted therapies. Cytokine. 2023;168:156235. https://doi.org/10.1016/j.cyto.2023.156235

Göv E and Kaynak Bayrak G. Drug repurposing analysis with co-expressed genes identifies novel drugs and small molecules for bladder cancer. Journal of Scientific Reports-A. 2024:70–81. https://doi.org/10.59313/jsr-a.1397224

Öz A. Regulatory role of TRPM7 cation channels on neuronal hypoxia model. Indian Journal of Biochemistry and Biophysics. 2023;60:836–43. https://doi.org/10.56042/ijbb.v60i11.4467

Kuleshov MV, Jones MR, Rouillard AD, et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Research. 2016;44:W90-7. https://doi.org/10.1093/nar/gkw377

Höflich KM, Beyer C, Clarner T, et al. Acute axonal damage in three different murine models of multiple sclerosis: a comparative approach. Brain Research. 2016;1650:125–33. https://doi.org/10.1016/j.brainres.2016.08.048

Kipp M, Clarner T, Dang J, et al. The cuprizone animal model: new insights into an old story. Acta Neuropathologica. 2009;118:723–36. https://doi.org/10.1007/s00401-009-0591-3

Marino Y, Arangia A, Cordaro M, et al. Analysis of the influence of IL-6 and the activation of the JAK/STAT3 pathway in fibromyalgia. Biomedicines. 2023;11. https://doi.org/10.3390/biomedicines11030792

Redza-Dutordoir M and Averill-Bates DA. Activation of apoptosis signalling pathways by reactive oxygen species. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 2016;1863:2977–92. https://doi.org/10.1016/j.bbamcr.2016.09.012

Zirngibl M, Assinck P, Sizov A, et al. Oligodendrocyte death and myelin loss in the cuprizone model: an updated overview of the intrinsic and extrinsic causes of cuprizone demyelination. Molecular Neurodegeneration. 2022;17:1–28. https://doi.org/10.1186/s13024-022-00538-8

Voskuhl RR, Itoh N, Tassoni A, et al. Gene expression in oligodendrocytes during remyelination reveals cholesterol homeostasis as a therapeutic target in multiple sclerosis. Proceedings of the National Academy of Sciences of the United States of America. 2019;116:10130–9. https://doi.org/10.1073/pnas.1821306116

Shiri E, Pasbakhsh P, Borhani-Haghighi M, et al. Mesenchymal stem cells ameliorate cuprizone-induced demyelination by targeting oxidative stress and mitochondrial dysfunction. Cellular and Molecular Neurobiology. 2021;41:1467–81. https://doi.org/10.1007/s10571-020-00910-6

Jiménez-Jiménez FJ, Alonso-Navarro H, Salgado-Cámara P, et al. Antioxidant therapies in the treatment of multiple sclerosis. Biomolecules. 2024;14. https://doi.org/10.3390/biom14101266

Nicola MA, Attaai AH, Abdel-Raheem MH, et al. Neuroprotective effects of rutin against cuprizone-induced multiple sclerosis in mice. Inflammopharmacology. 2024;32:1295–315. https://doi.org/10.1007/s10787-024-01442-x

Traiffort E, Kassoussi A, Zahaf A, et al. Astrocytes and microglia as major players of myelin production in normal and pathological conditions. Frontiers in Cellular Neuroscience. 2020;14:79. https://doi.org/10.3389/fncel.2020.00079

Published

31-12-2024

How to Cite

1.
Öz A. A bioinformatics approach to cuprizone model of multiple sclerosis: Focus on glial cells: Glial cell pathways in MS model. Neuro-Cell Mol Res. 2024;1(3):95-102. doi:10.5281/zenodo.14557832

Similar Articles

You may also start an advanced similarity search for this article.